188 related articles for article (PubMed ID: 22515093)
1. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model.
Babu A; Jeyasubramanian K; Gunasekaran P; Murugesan R
J Biomed Nanotechnol; 2012 Feb; 8(1):43-56. PubMed ID: 22515093
[TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol-modified gelatin/polylactic acid nanoparticles for enhanced photodynamic efficacy of a hypocrellin derivative in vitro.
Babu A; Periasamy J; Gunasekaran A; Kumaresan G; Naicker S; Gunasekaran P; Murugesan R
J Biomed Nanotechnol; 2013 Feb; 9(2):177-92. PubMed ID: 23627044
[TBL] [Abstract][Full Text] [Related]
3. Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo.
Li J; Yao S; Wang K; Lu Z; Su X; Li L; Yuan C; Feng J; Yan S; Kong B; Song K
Cancer Sci; 2018 Jun; 109(6):1958-1969. PubMed ID: 29617063
[TBL] [Abstract][Full Text] [Related]
4. Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system.
Li Z; Sun L; Lu Z; Su X; Yang Q; Qu X; Li L; Song K; Kong B
Int J Oncol; 2015 Sep; 47(3):1070-6. PubMed ID: 26165140
[TBL] [Abstract][Full Text] [Related]
5. Development of copolymeric nanoparticles of hypocrellin B: Enhanced phototoxic effect and ocular distribution.
Krishnaswami V; Ponnusamy C; Sankareswaran S; Paulsamy M; Madiyalakan R; Palanichamy R; Kandasamy R; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():26-36. PubMed ID: 29055734
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
Chin W; Lau W; Cheng C; Olivo M
Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
[TBL] [Abstract][Full Text] [Related]
7. Hypocrellin B and paclitaxel-encapsulated hyaluronic acid-ceramide nanoparticles for targeted photodynamic therapy in lung cancer.
Chang JE; Cho HJ; Yi E; Kim DD; Jheon S
J Photochem Photobiol B; 2016 May; 158():113-21. PubMed ID: 26967521
[TBL] [Abstract][Full Text] [Related]
8. A novel water-soluble nanoparticles of hypocrellin B and their interaction with a model protein: C-phycocyanin.
Zhao B; Xie J; Zhao J
Biochim Biophys Acta; 2004 Jan; 1670(2):113-20. PubMed ID: 14738993
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B.
Jiang Y; Leung AW; Wang X; Zhang H; Xu C
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):600-6. PubMed ID: 24284117
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antitumor activity of a novel hypocrellin B derivative for photodynamic therapy.
Zhao H; Yin R; Chen D; Ren J; Wang Y; Zhanga J; Deng H; Wang Y; Qiu H; Huang N; Zou Q; Zhao J; Gu Y
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):204-12. PubMed ID: 24534694
[TBL] [Abstract][Full Text] [Related]
11. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
[TBL] [Abstract][Full Text] [Related]
12. Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo.
Li T; Hou X; Deng H; Zhao J; Huang N; Zeng J; Chen H; Gu Y
Photochem Photobiol Sci; 2015 May; 14(5):972-81. PubMed ID: 25793654
[TBL] [Abstract][Full Text] [Related]
13. Photocytotoxicity of hypocrellin B (HB) was enhanced by liposomalization in vitro.
Zhou Z; Zhang L; Liu H; Zhang Q; Liu B; Ai P; Ma H; Liu W; Li Z; Sheng W; Zeng Y; Zhong R
Int J Toxicol; 2011 Mar; 30(2):174-80. PubMed ID: 21536921
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable Hypocrellin B nanoparticles coated with neutrophil membranes for hepatocellular carcinoma photodynamics therapy effectively via JUNB/ROS signaling.
Zhang Z; Li D; Cao Y; Wang Y; Wang F; Zhang F; Zheng S
Int Immunopharmacol; 2021 Oct; 99():107624. PubMed ID: 34343939
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy.
Wang ZJ; He YY; Huang CG; Huang JS; Huang YC; An JY; Gu Y; Jiang LJ
Photochem Photobiol; 1999 Nov; 70(5):773-80. PubMed ID: 10568169
[TBL] [Abstract][Full Text] [Related]
16. A new sol-gel silica nanovehicle preparation for photodynamic therapy in vitro.
Zhou L; Liu JH; Zhang J; Wei SH; Feng YY; Zhou JH; Yu BY; Shen J
Int J Pharm; 2010 Feb; 386(1-2):131-7. PubMed ID: 19922781
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of hypocrellin pharmacokinetics in phototherapy.
Ali SM; Olivo M
Int J Oncol; 2002 Dec; 21(6):1229-37. PubMed ID: 12429972
[TBL] [Abstract][Full Text] [Related]
18. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
[TBL] [Abstract][Full Text] [Related]
19. Sonodynamic and photodynamic mechanisms of action of the novel hypocrellin sonosensitizer, SL017: mitochondrial cell death is attenuated by 11, 12-epoxyeicosatrienoic acid.
El-Sikhry HE; Miller GG; Madiyalakan MR; Seubert JM
Invest New Drugs; 2011 Dec; 29(6):1328-36. PubMed ID: 20676746
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-Enhanced Self-Exciting Photodynamic Therapy Based on Hypocrellin B.
Ding Y; Liu W; Wu J; Zheng X; Ge J; Ren H; Zhang W; Lee CS; Wang P
Chem Asian J; 2021 May; 16(10):1221-1224. PubMed ID: 33881805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
